JP2015511122A5 - - Google Patents

Download PDF

Info

Publication number
JP2015511122A5
JP2015511122A5 JP2014554934A JP2014554934A JP2015511122A5 JP 2015511122 A5 JP2015511122 A5 JP 2015511122A5 JP 2014554934 A JP2014554934 A JP 2014554934A JP 2014554934 A JP2014554934 A JP 2014554934A JP 2015511122 A5 JP2015511122 A5 JP 2015511122A5
Authority
JP
Japan
Prior art keywords
amount
tissue
subject
rna
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014554934A
Other languages
English (en)
Japanese (ja)
Other versions
JP6320302B2 (ja
JP2015511122A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/023471 external-priority patent/WO2013113012A2/en
Publication of JP2015511122A publication Critical patent/JP2015511122A/ja
Publication of JP2015511122A5 publication Critical patent/JP2015511122A5/ja
Application granted granted Critical
Publication of JP6320302B2 publication Critical patent/JP6320302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014554934A 2012-01-27 2013-01-28 無細胞rnaをプロファイリングおよび定量するための方法 Active JP6320302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261591642P 2012-01-27 2012-01-27
US61/591,642 2012-01-27
PCT/US2013/023471 WO2013113012A2 (en) 2012-01-27 2013-01-28 Methods for profiling and quantitating cell-free rna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017008768A Division JP2017063799A (ja) 2012-01-27 2017-01-20 無細胞rnaをプロファイリングおよび定量するための方法

Publications (3)

Publication Number Publication Date
JP2015511122A JP2015511122A (ja) 2015-04-16
JP2015511122A5 true JP2015511122A5 (enExample) 2016-03-03
JP6320302B2 JP6320302B2 (ja) 2018-05-09

Family

ID=48874081

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014554934A Active JP6320302B2 (ja) 2012-01-27 2013-01-28 無細胞rnaをプロファイリングおよび定量するための方法
JP2017008768A Pending JP2017063799A (ja) 2012-01-27 2017-01-20 無細胞rnaをプロファイリングおよび定量するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017008768A Pending JP2017063799A (ja) 2012-01-27 2017-01-20 無細胞rnaをプロファイリングおよび定量するための方法

Country Status (9)

Country Link
US (15) US20130252835A1 (enExample)
EP (2) EP3584327A1 (enExample)
JP (2) JP6320302B2 (enExample)
CN (2) CN108359711A (enExample)
AU (1) AU2013211850B8 (enExample)
CA (1) CA2863035C (enExample)
HK (1) HK1211624A1 (enExample)
SG (2) SG11201505515XA (enExample)
WO (1) WO2013113012A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8583380B2 (en) 2008-09-05 2013-11-12 Aueon, Inc. Methods for stratifying and annotating cancer drug treatment options
CA2779750C (en) 2009-11-06 2019-03-19 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
CN103228798B (zh) 2010-09-24 2015-12-09 斯坦福大学托管董事会 使用固定的引物直接捕获、扩增及测序靶标dna
WO2015069900A1 (en) * 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
US20160289762A1 (en) 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
EP3584327A1 (en) 2012-01-27 2019-12-25 The Board of Trustees of the Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US10689652B2 (en) 2013-10-02 2020-06-23 The Regents Of The University Of California Methods for immortalization of epithelial cells
WO2015069933A1 (en) * 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Circulating cell-free dna for diagnosis of transplant rejection
CN105829589B (zh) 2013-11-07 2021-02-02 小利兰·斯坦福大学理事会 用于分析人体微生物组及其组分的无细胞核酸
US20170211143A1 (en) 2014-07-25 2017-07-27 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
ES2790823T3 (es) 2014-11-14 2020-10-29 Liquid Genomics Inc Uso de ARN sin células circulante para el diagnóstico y/o la monitorización de cáncer
AU2016264102A1 (en) 2015-05-18 2017-12-21 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
US10889861B2 (en) * 2015-06-17 2021-01-12 The Translational Genomics Research Institute Systems and methods for obtaining biological molecules from a sample
US10692797B2 (en) * 2015-06-30 2020-06-23 Laird Technologies, Inc. Thermal interface materials with low secant modulus of elasticity and high thermal conductivity
WO2017062517A1 (en) * 2015-10-06 2017-04-13 The Regents Of The University Of California Non-coding rnas linked to immortality and associated methods and compositions
EP3371730A4 (en) * 2015-11-04 2019-06-19 Metabolon, Inc. AUTOMATED SAMPLE QUALITY ASSESSMENT
EP3433382B1 (en) 2016-03-25 2021-09-01 Karius, Inc. Synthetic nucleic acid spike-ins
WO2018191563A1 (en) 2017-04-12 2018-10-18 Karius, Inc. Sample preparation methods, systems and compositions
US20200165685A1 (en) * 2017-05-10 2020-05-28 Nantomics, Llc Circulating rna for detection, prediction, and monitoring of cancer
TWI782020B (zh) * 2017-05-16 2022-11-01 香港中文大學 整合單細胞及血漿游離rna分析
US12444478B2 (en) 2017-10-23 2025-10-14 Cz Biohub Sf, Llc Noninvasive molecular clock for fetal development predicts gestational age and preterm delivery
KR20200085783A (ko) 2017-10-27 2020-07-15 주노 다이어그노스틱스, 인크. 초저용량 액체 생검을 위한 장치, 시스템 및 방법
WO2019094363A2 (en) 2017-11-07 2019-05-16 Nanthealth Labs, Inc. Targeted cell free nucleic acid analysis
CA3082601A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
US12462935B2 (en) 2018-03-30 2025-11-04 Nucleix Ltd. Deep learning-based methods, devices, and systems for prenatal testing
SG11202102954QA (en) 2018-10-04 2021-04-29 Bluestar Genomics Inc Simultaneous, sequencing-based analysis of proteins, nucleosomes, and cell-free nucleic acids from a single biological sample
EP3874042A4 (en) * 2018-10-29 2023-06-28 Molecular Stethoscope, Inc. Characterization of bone marrow using cell-free messenger-rna
DK4428234T3 (da) 2018-11-21 2026-01-26 Karius Inc Direkte-til-bibliotek-fremgangsmåder, systemer og sammensætninger
US11512349B2 (en) 2018-12-18 2022-11-29 Grail, Llc Methods for detecting disease using analysis of RNA
EP3914731A1 (en) * 2019-01-24 2021-12-01 Illumina, Inc. Methods and systems for monitoring organ health and disease
GB2612911B (en) * 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
AU2020253585A1 (en) * 2019-04-02 2021-11-18 Mission Bio, Inc. Methods, systems, and apparatus for nucleic acid detection
US11365441B2 (en) 2019-05-22 2022-06-21 Mission Bio, Inc. Method and apparatus for simultaneous targeted sequencing of DNA, RNA and protein
US11948684B2 (en) * 2019-06-20 2024-04-02 Latha Chakravarthy Diagnostic process for disease detection using gene expression based multi layer PCA classifier
CN110964800B (zh) * 2019-09-20 2021-10-22 北京航空航天大学 用于预测早产风险的cfRNA标志物
EP4055180A4 (en) * 2019-11-05 2023-12-06 Cofactor Genomics, Inc. METHODS AND SYSTEMS FOR PROCESSING COMPLEX DATA SETS USING ARTIFICIAL INTELLIGENCE AND DECONVOLUTION
AU2020378080B2 (en) * 2019-11-08 2026-02-19 Regeneron Pharmaceuticals, Inc. Accurate and robust information-deconvolution from bulk tissue transcriptomes
US20230008870A1 (en) * 2019-12-20 2023-01-12 University Of Utah Research Foundation Methods and compositions for monitoring and diagnosing healthy and disease states
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
WO2021188825A1 (en) * 2020-03-18 2021-09-23 Michael Nerenberg Systems and methods of detecting a risk of alzheimer's disease using a circulating-free mrna profiling assay
MX2023001781A (es) * 2020-08-13 2023-04-26 Mirvie Inc Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.
WO2024182491A1 (en) * 2023-02-28 2024-09-06 Virginia Commonwealth University Polygenic risk estimator for cervical length change during pregnancy

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629147A (en) 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5432054A (en) 1994-01-31 1995-07-11 Applied Imaging Method for separating rare cells from a population of cells
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20080009467A1 (en) 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
US6727066B2 (en) 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
US6977162B2 (en) * 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
EP1506395A2 (en) 2002-05-10 2005-02-16 Phase-1 Molecular Toxicology Inc. Liver inflammation predictive genes
AU2003272204A1 (en) 2002-07-12 2004-02-02 The Johns Hopkins University Neuronal and retinal gene expression patterns
WO2004007673A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Neuronal gene expression patterns
CA2513292C (en) 2003-01-17 2016-04-05 The Chinese University Of Hong Kong Circulating mrna as diagnostic markers for pregnancy-related disorders
US20060003342A1 (en) * 2004-01-15 2006-01-05 Bianchi Diana W Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
EP1877574A4 (en) * 2004-07-21 2009-05-06 Univ California SPEICHELTRANSKRIPTOMDIAGNOSE
US7713693B1 (en) * 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
CA2528531A1 (en) * 2005-01-06 2006-07-06 Mount Sinai Hospital Markers of pre-term labor
KR100686816B1 (ko) * 2005-07-22 2007-02-26 삼성에스디아이 주식회사 리튬 이차 전지
SI3002338T1 (sl) * 2006-02-02 2019-11-29 Univ Leland Stanford Junior Neinvaziven genetski pregled zarodka z digitalno analizo
WO2007146229A2 (en) 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2008132752A2 (en) * 2007-05-01 2008-11-06 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for predicting cancer metastasis
WO2009009457A1 (en) 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
AU2008289447B2 (en) * 2007-08-22 2014-09-04 Trovagene, Inc. Methods of using miRNA for detection of in vivo cell death
US8298768B2 (en) * 2007-11-29 2012-10-30 Complete Genomics, Inc. Efficient shotgun sequencing methods
AU2009207291B2 (en) * 2008-01-27 2014-11-06 Mor Research Applications Methods and compositions for diagnosing complications of pregnancy
EP2283155A4 (en) * 2008-05-01 2011-05-11 Swedish Health Services DIAGNOSTIC TEST FOR BREAKFAST
WO2009143576A1 (en) 2008-05-27 2009-12-03 Adelaide Research & Innovation Pty Ltd Polymorphisms associated with pregnancy complications
WO2009149026A2 (en) * 2008-06-01 2009-12-10 Tufts Medical Center, Inc. Genomic approaches to fetal treatment and diagnosis
US7888030B2 (en) * 2008-08-21 2011-02-15 King's College London Biomarkers
WO2010045470A2 (en) 2008-10-15 2010-04-22 Dana-Farber Cancer Institute, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders
EP2365804B1 (en) 2008-11-13 2015-05-06 Modgene, Llc Reduction of amyloid-beta load in non-brain tissue
US20110189679A1 (en) * 2009-09-11 2011-08-04 Nugen Technologies, Inc. Compositions and methods for whole transcriptome analysis
CN102741426B (zh) 2009-09-11 2015-03-25 香港中文大学 用于评估肝病变的方法
WO2011071893A1 (en) * 2009-12-08 2011-06-16 Cedars-Sinai Medical Center Diagnostic biomarker to identify women at risk for preterm delivery
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
JP5755326B2 (ja) 2010-06-11 2015-07-29 日立化成株式会社 腎機能の特徴を決定する方法
JP2013531799A (ja) * 2010-07-08 2013-08-08 プロノタ エヌ.ヴェ. 妊娠の高血圧障害についてのバイオマーカー
MX382244B (es) * 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
ES2627120T3 (es) 2011-07-08 2017-07-26 Helmholtz-Zentrum für Infektionsforschung GmbH Medicamento para el tratamiento del cáncer de hígado
EP2742155B1 (en) 2011-08-08 2018-01-24 Advanced Genomic Technology LLC Biomarker for alzheimer's disease and/or mild cognitively impairment
CA3069089A1 (en) 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
JP6652781B2 (ja) 2011-09-30 2020-02-26 ソマロジック・インコーポレーテッド 心血管系リスクイベントの予測およびその使用
WO2013066764A2 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Alzheimer's disease signature markers and methods of use
EP3584327A1 (en) * 2012-01-27 2019-12-25 The Board of Trustees of the Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US20160289762A1 (en) * 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
US9938580B2 (en) 2012-03-14 2018-04-10 Ruprecht-Karls-Universität Heidelberg Epigenetic signatures as marker for cardiomyopathies and myocardial insufficiencies
US10054599B2 (en) * 2013-03-12 2018-08-21 Agency For Science, Technology And Research (A*Star) Pre-eclampsia biomarkers
US9612248B2 (en) 2013-03-15 2017-04-04 Somalogic, Inc. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
JP2018518169A (ja) 2015-06-05 2018-07-12 レグルス セラピューティクス インコーポレイテッド 非アルコール性脂肪肝疾患バイオマーカー
ES2980812T3 (es) 2015-09-14 2024-10-03 Genfit Métodos para diagnosticar y evaluar la esteatohepatitis no alcohólica
US20190071795A1 (en) 2016-03-09 2019-03-07 Molecular Stethoscope, Inc. Methods and systems for detecting tissue conditions

Similar Documents

Publication Publication Date Title
JP2015511122A5 (enExample)
Shabaninejad et al. Electrochemical-based biosensors for microRNA detection: Nanotechnology comes into view
JP7679306B2 (ja) 腫瘍モデルの同定のための方法および組成物
JP7678837B2 (ja) 妊娠高血圧腎症に特異的な循環rnaシグネチャー
TWI580788B (zh) 用於檢測川崎病的方法及套組
EP2733219A1 (en) Diagnostic miRNA markers for Alzheimer
CN109295218B (zh) 环状RNA标志物hsa_circ_0001788及其应用
JP2013505020A5 (enExample)
JP2010500867A5 (enExample)
CN104651513B (zh) 一种痛风血清miRNAs生物标志物及其表达量的检测方法
US20210189491A1 (en) DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES OF LONG NONCODING RNAs FOR PATHOLOGIES AND TOXICITIES INDUCING HEART DISORDERS
CN102628082B (zh) 基于高通量测序技术进行核酸定性定量检测的方法
US20140272993A1 (en) Method of sequencing a full microrna profile from cerebrospinal fluid
WO2013125691A1 (ja) テスト体液サンプルの分類方法
CN109504784B (zh) 用于预测人辅助生殖技术中早期胚胎质量的miRNA分子标志及其应用
CA2859081A1 (en) Method for the diagnosis and/or prognosis of acute renal damage
CN108977533B (zh) 一种用于预测慢性乙肝炎症损伤的miRNA组合物
CN113234817B (zh) 利用CpG位点甲基化水平检测早期肝癌的标志物
CN108728532A (zh) 一种微小rna标志物及其应用
CN105624308B (zh) 一种检测染色体16p11.2微缺失的产品
JP2013526869A5 (enExample)
CN110724743A (zh) 人血液中结直肠癌诊断相关的甲基化生物标记物及其应用
CN108424963A (zh) 血清中circ_0079591作为URSA诊断及妊娠结局评估标志物的应用
CN109136382A (zh) 一种对四种人体体液来源进行鉴定的方法和系统
CN108753949B (zh) 血清中circ_0082660作为URSA诊断及妊娠结局评估标志物的应用